Director/PDMR Shareholding

RNS Number : 2226L

GlaxoSmithKline PLC

06 January 2009

 



Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

I give below details of changes in the directors' interests in the Ordinary shares and American Depository Shares (ADSs) of GlaxoSmithKline plc.

On 31 December 2008, the Company's Non-Executive Directors were provisionally allocated the following awards over Ordinary shares and American Depository Shares (ADSs) in the Company through the annual reinvestment of dividends paid throughout 2008:

SmithKline Beecham Non-Executive Directors Retainer Fee and Share Allocation Award - Annual Dividend Reinvestment

Non-Executive Director	No. of Ordinary Shares	Average  Price (£)
Sir Ian Prosser	49.37	£12.58

GlaxoSmithKline Non-Executive Directors Automatic Share Award and Elected Share Award - Annual Dividend Reinvestment

Non-Executive Director	No. of Ordinary Shares	Average  Price (£)	No. of  ADSs	Average Price ($)
Sir Christopher Gent	1,243.53	12.58
Prof Sir Roy Anderson	37.59	12.58
Dr Stephanie Burns			82.69	36.51
Mr Lawrence Culp			727.54	36.51
Sir Crispin Davis	1,103.24	12.58
Sir Deryck Maughan			608.90	36.51
Dr Daniel Podolsky			184.23	36.51
Sir Ian Prosser	1,063.89	12.58
Dr Ronaldo Schmitz	875.20	12.58
Mr Tom de Swaan	102.19	12.58
Sir Robert Wilson	304.09	12.58

The Company and the Non-Executive Directors were informed of these allocations on 5 January 2009.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

S M Bicknell

Company Secretary

6 January 2009

 

END

 

 

RDSDQLFBKFBLBBQ